FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Propylthiouracil from Actavis Pharma, Inc., under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Hyperthyroidism
• Thyrotoxic Crisis

Drugs mentioned

• Propylthiouracil (propylthiouracil)

Snippet

SUPPL AP for PROPYLTHIOURACIL (PROPYLTHIOURACIL)